From Declaration to Action: Antimicrobial Resistance Initiatives Centre Stage at Jeddah Conference
Jeddah, Saudi Arabia, November 14, 2024 – Antimicrobial resistance (AMR) has emerged as a major global health challenge, threatening the effectiveness of antibiotics and endangering the health of populations worldwide. To address this crisis, the Global AMR Innovation Fund, in collaboration with the World Health Organization (WHO), hosted a high-level conference in Jeddah, Saudi Arabia, from November 12-14, 2024.
The conference, titled “From Declaration to Action: Accelerating Progress in Antimicrobial Resistance,” brought together over 500 participants from governments, international organizations, academia, and the private sector. Attendees included:
- Dr. Tedros Adhanom Ghebreyesus, Director-General of the WHO
- Prince Faisal bin Bandar bin Abdulaziz Al Saud, Governor of Makkah Province
- Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, USA
- Dr. Gan Quan, Assistant Director-General for the Department of Antimicrobial Resistance, WHO
The conference served as a platform for:
- Reviewing progress: Participants assessed the implementation of the Declaration on Combatting Antimicrobial Resistance, adopted by the WHO in 2015.
- Identifying challenges: Attendees discussed the obstacles to AMR control, including inadequate surveillance, limited access to diagnostics and treatments, and poor infection prevention and control practices.
- Developing solutions: The conference showcased innovative approaches to AMR, including the development of new antibiotics, vaccines, and diagnostic tools, as well as initiatives to promote responsible antibiotic use.
Key outcomes of the conference include:
- Global AMR Action Plan: A comprehensive plan outlining concrete actions to accelerate progress in AMR control, with specific targets and timelines.
- International Collaboration: A renewed commitment to strengthening international collaboration on AMR, including the sharing of data, resources, and expertise.
- Investment in Innovation: Increased funding for research and development to advance the development and deployment of new AMR solutions.
“AMR is one of the most pressing global health challenges of our time,” said Dr. Ghebreyesus. “This conference has been an important opportunity to take stock of our progress, identify challenges, and develop concrete actions to address this threat.”
The conference in Jeddah marked a significant step forward in the global fight against AMR. By bringing together stakeholders from around the world, it fostered collaboration, innovation, and a renewed commitment to protecting human health from the dangers of antimicrobial resistance.
From Declaration to action: Antimicrobial resistance initiatives centre stage at Jeddah conference
The AI has provided us with the news.
I’ve asked Google Gemini the following question, and here’s its response.
Top Stories a new article on 2024-11-14 12:00 titled “From Declaration to action: Antimicrobial resistance initiatives centre stage at Jeddah conference”. Please write a detailed article on this news item, including any relevant information. Answers should be in English.
29